Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial

Published:2024 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Chew Chun Keat,Wang Ruijie,Bavanandan Sunita,Zainudin Norliza,Zhao Xiaoyuan,Ahmed Sumeyya,Nair Damenthi,Hou Li-Hua,Yahya Rosnawati,Ch'ng Shereen Suyin,Pang Lai Hui,Abdul Aziz Azrini,Huang Hai-Tao,Rajasuriar Reena,Wu Shi-Po,Zhang Zhe,Wang Xuewen,Zhu Tao,Lim Teck Onn,Gou Jin-Bo,Ng Sharon Shi Min,Group CoVaxBooster Study

Publisher

Elsevier BV

Reference40 articles.

1. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study;O J Watson;Lancet Infect Dis,2022

2. Augmented neutralisation resistance of emerging omicron subvariants BA;P Arora;Lancet Infect Dis,2022

3. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial;G Li;Lancet,2022

4. A novel coronavirus from patients with pneumonia in China;N Zhu;N Engl J Med,2019

5. Atlas of currently available human neutralising antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3;M Huang;Immunity,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP